This undated photo provided by US WorldMeds shows Lucemyra. Federal regulators have approved the first nonopioid treatment to ease withdrawal symptoms from quitting opioids. (US WorldMeds via AP)
This undated photo provided by US WorldMeds shows Lucemyra. Federal regulators have approved the first nonopioid treatment to ease withdrawal symptoms from quitting opioids. (US WorldMeds via AP)
This undated photo provided by US WorldMeds shows Lucemyra. Federal regulators have approved the first nonopioid treatment to ease withdrawal symptoms from quitting opioids. (US WorldMeds via AP)

FDA approves 1st nonopioid drug to ease withdrawal symptoms

May 16, 2018 07:07 PM